CIK: 1672333 - Address: 611 Gateway Boulevard, Suite 710, South San Francisco, CA 94080
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
8/11/21 09:14
8/9/21
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsLevy HowardCAOChief MeP23.6201324D
2/22/21 21:33
2/9/21
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsLevy HowardCAOChief MeP84.8102823I
8/12/20 16:11
8/10/20
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsLevy HowardCAOChief MeP94.8102922D
3/17/20 16:23
3/16/20
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsLevy HowardCAOChief MeP104.05031420D
5/22/19 12:23
5/21/19
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsLevy HowardCAOChief MeM.d204.63041632M
2/4/19 16:53
1/31/19
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsLevy HowardCAOChief MeM.d74.6302199D
11/27/18 17:01
11/26/18
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsLevy HowardCAOChief MeM.d14.630028D
11/16/18 17:56
11/16/18
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsLevy HowardCAOChief MeM.d14.630028D
11/16/18 17:56
11/16/18
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsLevy HowardCAOChief MeS.d-211.0000-28D
5/4/18 16:58
5/3/18
CBIOCatalyst Biosciences, Inc.HealthDrugPharmaceutical PreparationsLevy HowardCAOChief MeM.d354.6308New8D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact